Deciphera Pharmaceuticals, Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
Deciphera Pharmaceuticals, Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2018-03-28
- Deciphera Pharmaceuticals, Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2017 was $0.00.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-28 |